BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2466629)

  • 1. [Solid-phase immunosorption of antibodies against specific brain antigen from the blood of rats with experimental break of the blood-brain barrier].
    Chekhonin VP; Morozov GV; Cherkasova TA; Leĭkin IuA
    Dokl Akad Nauk SSSR; 1988; 302(6):1511-3. PubMed ID: 2466629
    [No Abstract]   [Full Text] [Related]  

  • 2. [Specific brain antigens as the indicators of the blood-brain barrier permeability in Alzheimer's disease].
    Groppa SA; Chekhonin VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):50-2. PubMed ID: 1723824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunoenzymatic detection of specific brain antigens as a criterion of the permeation of blood-brain barrier in rats with acute cerebral ischemia].
    Chekhonin VP; Morozov GV; Markovkin VM; Blizniukova AS
    Biull Eksp Biol Med; 1988 May; 105(5):581-3. PubMed ID: 2454685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the state of the blood-brain barrier in rats following experimental neurosensitization].
    Trekova NA; Maĭzelis MIa; Kogan RD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(7):872-5. PubMed ID: 465154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunoenzyme analysis of the antigenic orientation of "anti-brain" autoantibodies in the serum of epileptics].
    Poletaev AB; Karlov VA; Pomogaeva MV; Selifanova OP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(6):831-3. PubMed ID: 4024806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protective reaction of brain cells during change in permeability of the blood-brain barrier].
    Khokhlov AP; Fetisova IG; Podlesnyĭ AM; Chekhonin VP; Malakhovskiĭ VK
    Vopr Med Khim; 1993; 39(4):25-7. PubMed ID: 8379108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoenzyme detection of specific brain antigens as a criterion of the permeability of the hemato-encephalic barrier in rats following acute gamma irradiation].
    Chekhonin VP; Morozov GV; Riabukhin IA
    Biull Eksp Biol Med; 1989 Apr; 107(4):464-6. PubMed ID: 2470443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic identity of alpha-macrofetoprotein and acute phase protein in the rat.
    Boss JH; Dishon T; Rosenmann E
    Biomedicine; 1975 Jun; 23(6):196-7. PubMed ID: 55277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Brain barriers and the problem of autoimmunity in neurology].
    Nadareishvili ZG; Malashkhiia IuA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):3-7. PubMed ID: 2800807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical localization of immunoglobulins in the rat brain: relationship to the blood-brain barrier.
    Aihara N; Tanno H; Hall JJ; Pitts LH; Noble LJ
    J Comp Neurol; 1994 Apr; 342(4):481-96. PubMed ID: 8040362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineural antibodies in blood sera of rats subjected to global cerebral ischemia.
    Mossakowski MJ; Krajewski S
    Neuropatol Pol; 1988; 26(2):163-74. PubMed ID: 3071744
    [No Abstract]   [Full Text] [Related]  

  • 12. Transport of hydrophobized fragments of antibodies through the blood-brain barrier.
    Chekhonin VP; Ryabukhin IA; Zhirkov YA; Kashparov IA; Dmitriyeva TB
    Neuroreport; 1995 Dec; 7(1):129-32. PubMed ID: 8742434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible utilization of extracorporeal immunoadsorption and other immunologic methods in the treatment of schizophrenia.
    Strahilevitz M
    Birth Defects Orig Artic Ser; 1978; 14(5):261-76. PubMed ID: 80237
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoimmune model of schizophrenia with special reference to antibrain antibodies.
    Pandey RS; Gupta AK; Chaturvedi UC
    Biol Psychiatry; 1981 Dec; 16(12):1123-36. PubMed ID: 6186298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage-mediated demyelination: the role of phospholipases and antibody.
    Trotter J; Smith ME
    Prog Clin Biol Res; 1984; 146():55-60. PubMed ID: 6201923
    [No Abstract]   [Full Text] [Related]  

  • 16. Allografts of CNS tissue possess a blood-brain barrier: III. Neuropathological, methodological, and immunological considerations.
    Broadwell RD; Baker BJ; Ebert PS; Hickey WF
    Microsc Res Tech; 1994 Apr; 27(6):471-94. PubMed ID: 8012052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term changes in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat.
    Stolp HB; Dziegielewska KM; Ek CJ; Potter AM; Saunders NR
    Eur J Neurosci; 2005 Dec; 22(11):2805-16. PubMed ID: 16324115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Permeability of the blood-brain barrier in severe craniocerebral trauma].
    Churliaev IuA; Nikiforova NV; Shukevich DL; Lykova OF; Konysheva TV; Bykov KV
    Anesteziol Reanimatol; 2002; (6):17-9. PubMed ID: 12611150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of neuroallergy in the pathogenesis of multiple sclerosis].
    Vilkov GA; Martirosian VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):206-9. PubMed ID: 3885657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage.
    Jiang J; Wang W; Sun YJ; Hu M; Li F; Zhu DY
    Eur J Pharmacol; 2007 Apr; 561(1-3):54-62. PubMed ID: 17303117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.